Active Shortage

CYCLOPHOSPHAMIDE FOR INJECTION USP

MARCAN PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of CYCLOPHOSPHAMIDE FOR INJECTION USP in Canada?

Yes. CYCLOPHOSPHAMIDE FOR INJECTION USP 1000MG has an active shortage reported to Health Canada (last updated November 9, 2026).

Why is CYCLOPHOSPHAMIDE FOR INJECTION USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will CYCLOPHOSPHAMIDE FOR INJECTION USP be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Affected strength1000MG

Report last updated2026-11-09

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

CYCLOPHOSPHAMIDE FOR INJECTION

STERIMAX INC

1000MG · DIN 02546736

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

PROCYTOX

BAXTER CORPORATION

200MG · DIN 02241797

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

Cyclophosphamide for Injection USP

Cyclophosphamide for Injection USP: Presence of particulate matter

Type I2026-10-30

Highest health risk

Possible match — not confirmed

DIN

02560216

Strength

1000MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

CYCLOPHOSPHAMIDE

See all CYCLOPHOSPHAMIDE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-11-09

Active Shortage

Disruption of the manufacture of the drug.

Other Products from MARCAN PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION USP

500MG · DIN 02537893

AMIKACIN SULFATE INJECTION USP

500MG · DIN 02481073

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02554364

BICNU

100MG · DIN 02555093

BICNU

100MG · DIN 00297763

BORTEZOMIB FOR INJECTION

3.5MG · DIN 02493306